The estimated Net Worth of Surendra K Ajjarapu is at least $1.87 Million dollars as of 20 May 2022. Mr Ajjarapu owns over 10,000 units of Trxade Health Inc stock worth over $1,570,850 and over the last 5 years he sold MEDS stock worth over $0. In addition, he makes $295,424 as Founder, Chairman, CEO und Treasurer & Sec. at Trxade Health Inc.
Sign up
Mr Ajjarapu MEDS stock SEC Form 4 insiders trading
Mr has made over 1 trades of the Trxade Health Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently he bought 10,000 units of MEDS stock worth $130,000,000 on 20 May 2022.
The largest trade he's ever made was buying 10,000 units of Trxade Health Inc stock on 20 May 2022 worth over $130,000,000. On average, Mr trades about 2,000 units every 0 days since 2020. As of 20 May 2022 he still owns at least 222,500 units of Trxade Health Inc stock.
You can see the complete history of Mr Ajjarapu stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Surendra K. Ajjarapu biography
Surendra K. Ajjarapu is the Founder, Chairman, CEO, Treasurer & Sec. at Trxade Health Inc.
What is the salary of Mr Ajjarapu?
As the Founder, Chairman, CEO und Treasurer & Sec. of Trxade Health Inc, the total compensation of Mr Ajjarapu at Trxade Health Inc is $295,424. There are no executives at Trxade Health Inc getting paid more.
How old is Mr Ajjarapu?
Mr Ajjarapu is 50, he's been the Founder, Chairman, CEO und Treasurer & Sec. of Trxade Health Inc since . There are 1 older and 1 younger executives at Trxade Health Inc. The oldest executive at Trxade Health Inc is Howard A. Doss, 67, who is the Chief Financial Officer.
What's Mr Ajjarapu's mailing address?
Surendra's mailing address filed with the SEC is 2420 BRUNELLO TRACE, , LUTZ, FL, 33558.
Insiders trading at Trxade Health Inc
Over the last 8 years, insiders at Trxade Health Inc have traded over $142,273 worth of Trxade Health Inc stock and bought 13,500 units worth $130,004,140 . The most active insiders traders include Michael L Peterson, Charles L Pope und Prashant Patel. On average, Trxade Health Inc executives and independent directors trade stock every 166 days with the average trade being worth of $28,424. The most recent stock trade was executed by Donald G. Fell on 25 August 2022, trading 1,500 units of MEDS stock currently worth $1,620.
What does Trxade Health Inc do?
trxade.com is quickly becoming the nation's largest web-based pharmaceutical purchasing and analytics system. our revolutionary supplier e-stores allow buyers to shop and compare products and pricing of pharmaceutical suppliers nationwide. this forward thinking platform creates supplier competition and drives down cost for the buyers like never before. our secure system also allows buyers to track all of their purchases in one, easy to manage location with analytical tools available to make more educated and informed purchasing decisions. trxade.com membership is offered only to licensed pharmaceutical buyers (pharmacies, long term care facilities, hospitals, physicians, etc.). our safe and secure system allows buyers to search for products, compare pricing and submit immediate purchase orders to some of the nation's most well known and respected suppliers.
What does Trxade Health Inc's logo look like?
Complete history of Mr Ajjarapu stock trades at Trxade Health Inc
Trxade Health Inc executives and stock owners
Trxade Health Inc executives and other stock owners filed with the SEC include:
-
Surendra K. Ajjarapu,
Founder, Chairman, CEO, Treasurer & Sec. -
Prashant Patel,
Founder, Pres, COO & Director -
Howard A. Doss,
Chief Financial Officer -
Jariel Morales,
Exec. VP -
David M. Saslow,
Inhouse Counsel -
Dr. Ramesh Kenchappa,
Chief Scientific Officer -
Howard A. Doss,
-
Donald G. Fell,
Director -
Surendra K Ajjarapu,
Chairman and CEO -
A. Jeffrey Newell,
Director -
Charles L Pope,
Director -
Pamela Tenaerts,
-
Christine L. Jennings,
Director -
Janet Huffman,
CFO, PAO, PFO -
Prashant Patel,
Interim CFO and Director -
Michael L Peterson,
Director